Recursion Pharmaceuticals, Inc. - Class A Common Stock (RXRX) stock analysis
RXRX · Recursion Pharmaceuticals, Inc. - Class A Common Stock
Latest recorded price: USD 2.90
Sector and industry: Healthcare · Biotechnology
Fiscal 2025 figures: revenue growth 23.3%, free cash flow margin -506.5%, ROIC -86.4%. The model flags 1 risk signal for this company (1 high severity).
Similar companies in Healthcare
- Rhythm Pharmaceuticals, Inc. - Common Stock (RYTM)
- SELLAS Life Sciences Group, Inc. - Common Stock (SLS)
- Summit Therapeutics Inc. (SMMT)
- Syndax Pharmaceuticals, Inc. (SNDX)
- Sarepta Therapeutics, Inc. (SRPT)
- Scholar Rock Holding Corporation (SRRK)
- Stoke Therapeutics, Inc. - Common Stock (STOK)
- Savara Inc. (SVRA)